Aseptic processing environmental monitoring procedures are inadequate in them filling line.
Inspection Record
Dr. Reddy's Laboratories Ltd. — FDA 483 Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
Thewe drug substance manufacturing process lacks adequate controls to prevent microbial contamination of in-process intermediates.
Your firm failed to ensure that operators working in aseptic manufacturing areas are adequately trained, as evidenced by deficient On-the-Job Training (OJT) records for personnel in them@ _ area.
A record as of the US FDA document published on 2026-11-13. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.